Oncolytic Virus Infographic
Oncolytic Virus Infographic

Oncolytic Virus Overview:

Oncolytic viruses (OVs) are organisms able to identify, infect, and lyse different cells in the tumour environment, aiming to stabilise and decrease the tumour progression. 


Oncolytic Virus Therapies: 175+


Oncolytic Virus Companies: 150+ 


Key Oncolytic Virus Companies

  • Genelux Corporation
  • Candel Therapeutics
  • CG Oncolgy
  • DNAtrix
  • SillaJen Biotherapeutics
  • Oncolytics Biotech
  • Wuhan Binhui Biotechnology
  • Oryx GmbH
  • Jiangsu Sinorda Biomedicine Co., Ltd
  • Virogin Biotech
  • Replimune
  • Viralytics
  • Oncolys Biopharma
  • Istari Oncology
  • Immvira Pharma
  • Seneca Therapeutics
  • Treovir, LLC
  • Targovax
  • Lokon Pharma
  • ORCA Therapeutics
  • Beijing SyngenTech
  • ViruCure
  • Tasly Pharmaceuticals
  • Turnstone Biologics
  • BioInvent
  • Transgene
  • Elicera Therapeutics
  • Orgenesis
  • Virttu Biologics
  • Imugene
  • Astellas Pharma
  • Wuhan Binhui Biotechnology Co., Ltd.
  • Mustang Bio
  • Virogin Biotech
  • Vaxiion Therapeutics
  • ImmVirX
  • Memgen
  • Replimune
  • Immvira Pharma
  • ViroCure
  • GeneMedicine
  • PsiOxus Therapeutics
  • VCN Biosciences
  • Candel therapeutics
  • Sorrento Therapeutics
  • Imugene Limited
  • Calidi Biotherapeutics
  • Replimune
  • TILT Biotherapeutics
  • Guangzhou Virotech Pharmaceutical
  • DNAtrix
  • Oncorus
  • BioEclipse Therapeutics
  • And several others.


Oncolytic Virus Report Assessment

  • Company Analysis
  • Therapeutic Assessment
  • Approved/Pipeline Assessment
  • Inactive drugs assessment
  • Unmet Needs


Oncolytic Virus Therapeutic Assessment:

  • By Product Type
  • By Stage and Product Type
  • By Route of Administration
  • By Stage and Route of Administration
  • By Molecule Type
  • By Stage and Molecule Type


Related Reports:

  • Oncolytic Virus Cancer Therapy Market Insight, Epidemiology and Market Forecast – 2032